Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Risk Evaluation With AI-CPA + HCS For Patients IN Whom Calcium is confirmEd to Improve Coronary Artery Disease Care

NCT07853716 is registered in ClinicalTrials.gov with HeartFlow, Inc. as lead sponsor.

NCT NCT07853716
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07853716 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Risk Evaluation With AI-CPA + HCS For Patients IN Whom Calcium is confirmEd to Improve Coronary Artery Disease Care
Lead sponsor
HeartFlow, Inc.
Phase
Not applicable
Overall status
Not yet recruiting
Start date
November 30, 2026
Completion date
June 30, 2029
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cad - coronary artery disease